These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26258966)

  • 1. [Diagnosing and therapy of gout].
    Pavelka K
    Vnitr Lek; 2015 Jun; 61(6):517-26. PubMed ID: 26258966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treat to target in gouty arthritis].
    Pavelka K
    Vnitr Lek; 2018; 64(2):185-190. PubMed ID: 29595284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2011 recommendations for the diagnosis and management of gout and hyperuricemia.
    Hamburger M; Baraf HS; Adamson TC; Basile J; Bass L; Cole B; Doghramji PP; Guadagnoli GA; Hamburger F; Harford R; Lieberman JA; Mandel DR; Mandelbrot DA; McClain BP; Mizuno E; Morton AH; Mount DB; Pope RS; Rosenthal KG; Setoodeh K; Skosey JL; Edwards NL
    Phys Sportsmed; 2011 Nov; 39(4):98-123. PubMed ID: 22293773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2011 Recommendations for the diagnosis and management of gout and hyperuricemia.
    Hamburger M; Baraf HS; Adamson TC; Basile J; Bass L; Cole B; Doghramji PP; Guadagnoli GA; Hamburger F; Harford R; Lieberman JA; Mandel DR; Mandelbrot DA; McClain BP; Mizuno E; Morton AH; Mount DB; Pope RS; Rosenthal KG; Setoodeh K; Skosey JL; Edwards NL;
    Postgrad Med; 2011 Nov; 123(6 Suppl 1):3-36. PubMed ID: 22156509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [ERRORS IN THE DIAGNOSTICS AND TREATMENT OF PATIENTS WITH GOUT AND THE ALGORITHM OF THERAPEUTIC TACTICS IN DIFFERENT PERIODS OF THE DISEASE (CLINICAL CASE)].
    Baidurin S; Bekenova F; Nakysh A; Akhmetzhanova S; Abai G
    Georgian Med News; 2020 Jun; (303):103-108. PubMed ID: 32841190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gout and comorbidities associated with hyperuricemia].
    Majdan M; Borys O
    Ann Acad Med Stetin; 2010; 56 Suppl 1():34-9. PubMed ID: 21365938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current management of gout: practical messages from 2016 EULAR guidelines.
    Nuki G; Doherty M; Richette P
    Pol Arch Intern Med; 2017 Apr; 127(4):267-277. PubMed ID: 28430170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New therapeutic options for gout].
    Richette P; Ottaviani S; Bardin T
    Presse Med; 2011 Sep; 40(9 Pt 1):844-9. PubMed ID: 21684104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of hyperuricemia, gout and other crystalline arthritidies.
    Lioté F
    Reumatismo; 2012 Jan; 63(4):276-83. PubMed ID: 22303534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gout: an update.
    Eggebeen AT
    Am Fam Physician; 2007 Sep; 76(6):801-8. PubMed ID: 17910294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purine metabolism and hyperuricemic states. 'The point of view of the rheumatologist'.
    Peronato G
    Contrib Nephrol; 2005; 147():1-21. PubMed ID: 15604602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gouty Arthritis: A Review of Acute Management and Prevention.
    Wilson L; Saseen JJ
    Pharmacotherapy; 2016 Aug; 36(8):906-22. PubMed ID: 27318031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hyperuricemia and gout].
    Gröbner W
    Dtsch Med Wochenschr; 2015 Oct; 140(21):1615-26. PubMed ID: 26488103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gout: an overview of available urate lowering therapies].
    Richette P
    Ann Pharm Fr; 2012 May; 70(3):133-8. PubMed ID: 22655581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Febuxostat: a selective xanthine oxidase inhibitor for the treatment of hyperuricemia and gout.
    Bruce SP
    Ann Pharmacother; 2006 Dec; 40(12):2187-94. PubMed ID: 17132810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gout and hyperuricemia.
    Harris MD; Siegel LB; Alloway JA
    Am Fam Physician; 1999 Feb; 59(4):925-34. PubMed ID: 10068714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the management of gout and hyperuricaemia.
    Hoskison TK; Wortmann RL
    Scand J Rheumatol; 2006; 35(4):251-60. PubMed ID: 16882587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gout: a review of its aetiology and treatment.
    Li EK
    Hong Kong Med J; 2004 Aug; 10(4):261-70. PubMed ID: 15299172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Febuxostat: a selective xanthine-oxidase/xanthine-dehydrogenase inhibitor for the management of hyperuricemia in adults with gout.
    Ernst ME; Fravel MA
    Clin Ther; 2009 Nov; 31(11):2503-18. PubMed ID: 20109996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathogenesis, diagnostics and therapy of gout].
    Zurek M
    Vnitr Lek; 2006; 52(7-8):736-41. PubMed ID: 16967617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.